Biosimilars – 2019 Year in Review
Life sciences attorneys John Adkisson, Tasha Francis, and Jenny Shmuel provide a review of current legal and regulatory developments that have had an impact on the U.S. biosimilar industry. Topics discussed during this webinar include:
- 2019 biosimilar approvals, launches, and anticipated launches
- Summary of FDA guidance in 2019
- Updates regarding pending court cases and appellate decisions
- 2019 IPR trends
- What to look forward to in 2020!
Download a copy of the slides here.
Tasha Francis, Ph.D.
Jenny Schmuel, Ph.D.